HOME
SEARCH
RSS FEED
SUBSCRIBE
Search Results - qing+rong+liu
3
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Novel Human Insulin Cα-Peptide as an Antagonist for Islet and Brain Amyloidosis
Abstract: Over 32 million Americans are living with Diabetes and newly diagnosed cases of type 1 and type 2 diabetes is increasing. A defining feature of type 2 diabetes mellitus (T2DM) is the accumulation of islet amyloid polypeptide (IAPP) fibrils in pancreatic islets. Such accumulations form amyloid plaques, referred to as islet amyloidosis. Mounting...
Published: 4/8/2024
|
Inventor(s):
Qing Rong Liu
,
Min Zhu
,
Pingbo Zhang
,
Josephine Egan
,
Luigi Ferrucci
Keywords(s):
Alzheimer’s Disease
,
Amyloidosis
,
C-peptide
,
DIABETES
,
Egan
,
insulin
,
Islet Amyloid Polypeptide
,
Liu
,
National Institute on Aging
,
NIA
Category(s):
Collaboration Sought > Licensing
,
Collaboration Sought > Collaboration
,
Application > Therapeutics
,
TherapeuticArea > Endocrinology
Glial Cell Line-Derived Neurotrophic Factor for the Treatment of Neurodegenerative Diseases and Diabetes
Abstract: The National Institute on Drug Abuse (NIDA) is seeking interested parties to license or co-develop GDNFOS peptides and non-coding RNAs as therapeutic agents for neurodegenerative diseases. Glial cell line-derived neurotrophic factor (GDNF) is a small human protein encoded by the GDNF gene. GDNF has been effective therapy in laboratory animal...
Published: 4/8/2024
|
Inventor(s):
Qing Rong Liu
Keywords(s):
ALS
,
GDNFOS3.
,
Glial Cell Line Derived Neurotrophic Factor (GDNF)
,
Multiple sclerosis
,
Parkinson's Disease
Category(s):
TherapeuticArea > Neurology
,
Collaboration Sought > Licensing
,
Application > Therapeutics
,
Collaboration Sought > Collaboration
Novel Human Islet Amyloid Polypeptides as Alzheimer’s Disease Biomarkers and Inhibitors of Amyloid Formation
Abstract: Over 34 million Americans are living with diabetes. An estimated 6.5 million Americans are living with Alzheimer’s disease (AD) and type 2 diabetes mellites (T2DM). Amyloidosis due to aggregation of amyloid-β is key pathogenic event in AD, whereas aggregation of mature islet amyloid polypeptide (IAPP37) in human islet leads to β-cell dysfunction....
Published: 12/17/2024
|
Inventor(s):
Qing Rong Liu
,
Min Zhu
,
Josephine Egan
Keywords(s):
Ad
,
Age-Associated Disease
,
Alzheimer’s Disease
,
Amyloidosis
,
Amyloids
,
Biomarkers
,
DIABETES
,
IAPP
,
Islet Amyloid Polypeptide Isoforms
,
Liu
,
National Institute on Aging
,
NIA
,
PEPTIDYL
Category(s):
Collaboration Sought > Collaboration
,
Collaboration Sought > Licensing
,
TherapeuticArea > Oncology
,
Application > Therapeutics
Home
|
Search
|
RSS
|
Subscribe
© 2025. All Rights Reserved. Powered by
Inteum